These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 31288243)

  • 21. Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial.
    Valery PC; Morris PS; Byrnes CA; Grimwood K; Torzillo PJ; Bauert PA; Masters IB; Diaz A; McCallum GB; Mobberley C; Tjhung I; Hare KM; Ware RS; Chang AB
    Lancet Respir Med; 2013 Oct; 1(8):610-620. PubMed ID: 24461664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eradication of
    Blanco-Aparicio M; Saleta Canosa JL; Valiño López P; Martín Egaña MT; Vidal García I; Montero Martínez C
    Chron Respir Dis; 2019; 16():1479973119872513. PubMed ID: 31480862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficiency of a self-administered outpatient parenteral antimicrobial therapy (s-opat) for infective endocarditis within the context of a shortened hospital admission based on hospital at home program.
    Pajarón M; Lisa M; Fernández-Miera MF; Dueñas JC; Allende I; Arnaiz AM; Sanroma-Mendizábal P; De Berrazueta JR; Fariñas MC;
    Hosp Pract (1995); 2017 Dec; 45(5):246-252. PubMed ID: 29090606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics, safety and cost-effectiveness analysis of self-administered outpatient parenteral antibiotic therapy via a disposable elastomeric continuous infusion pump at two county hospitals in Houston, Texas, United States.
    Karimaghaei S; Rao A; Chijioke J; Finch N; Nigo M
    J Clin Pharm Ther; 2022 Feb; 47(2):211-217. PubMed ID: 34699089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of a Belgian tertiary care outpatient parenteral antimicrobial therapy (OPAT) program.
    Quintens C; Steffens E; Jacobs K; Schuermans A; Van Eldere J; Lagrou K; De Munter P; Derdelinckx I; Peetermans WE; Spriet I
    Infection; 2020 Jun; 48(3):357-366. PubMed ID: 32060859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dedicated paediatric Outpatient Parenteral Antimicrobial Therapy medical support: a pre-post observational study.
    Mace AO; McLeod C; Yeoh DK; Vine J; Chen YP; Martin AC; Blyth CC; Bowen AC
    Arch Dis Child; 2018 Feb; 103(2):165-169. PubMed ID: 28847879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service.
    Durojaiye OC; Bell H; Andrews D; Ntziora F; Cartwright K
    Int J Antimicrob Agents; 2018 Jan; 51(1):26-32. PubMed ID: 28673610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolonged treatment with macrolides in adult patients with non-cystic fibrosis bronchiectasis: meta-analysis of randomized controlled trials.
    Zhuo GY; He Q; Xiang-Lian L; Ya-Nan Y; Si-Te F
    Pulm Pharmacol Ther; 2014 Oct; 29(1):80-8. PubMed ID: 24594263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhaled antibiotics in non-cystic fibrosis bronchiectasis: A meta-analysis.
    Xu L; Zhang F; Du S; Yu Q; Chen L; Long LH; Li YM; Jia AH
    Pharmazie; 2016 Sep; 71(9):491-498. PubMed ID: 29441843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy of inhaled antibiotics in non-cystic fibrosis bronchiectasis.
    Amaro R; Panagiotaraka M; Alcaraz V; Torres A
    Expert Rev Respir Med; 2018 Aug; 12(8):683-691. PubMed ID: 30010445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lung function, symptoms and inflammation during exacerbations of non-cystic fibrosis bronchiectasis: a prospective observational cohort study.
    Brill SE; Patel AR; Singh R; Mackay AJ; Brown JS; Hurst JR
    Respir Res; 2015 Feb; 16(1):16. PubMed ID: 25849856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective.
    Wai AO; Frighetto L; Marra CA; Chan E; Jewesson PJ
    Pharmacoeconomics; 2000 Nov; 18(5):451-7. PubMed ID: 11151398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for requiring intravenous antibiotic therapy in hospital and 30-day readmission for exacerbations of bronchiectasis.
    Velu PP; Bedi P; Turnbull K; Hill AT
    QJM; 2016 Nov; 109(11):723-729. PubMed ID: 27081209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Outpatient parenteral antimicrobial therapy (OPAT) in bone and joint infections].
    Galpérine T; Ader F; Piriou P; Judet T; Perronne C; Bernard L
    Med Mal Infect; 2006 Mar; 36(3):132-7. PubMed ID: 16580802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aerosolized antibiotics for non-cystic fibrosis bronchiectasis.
    Rubin BK; Williams RW
    Respiration; 2014; 88(3):177-84. PubMed ID: 25171580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcomes of a veterans affairs outpatient antimicrobial treatment program.
    Mohammadi S; MacKay K; Ward TT; Forrest GN
    South Med J; 2013 Jun; 106(6):345-9. PubMed ID: 23736174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Supervised self-administration of outpatient parenteral antibiotic therapy: a report from a large tertiary hospital in Australia.
    Subedi S; Looke DF; McDougall DA; Sehu MM; Playford EG
    Int J Infect Dis; 2015 Jan; 30():161-5. PubMed ID: 25603999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years.
    Matthews PC; Conlon CP; Berendt AR; Kayley J; Jefferies L; Atkins BL; Byren I
    J Antimicrob Chemother; 2007 Aug; 60(2):356-62. PubMed ID: 17566002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative microbiome analysis in cystic fibrosis and non-cystic fibrosis bronchiectasis.
    Motta H; Reuwsaat JCV; Lopes FC; Viezzer G; Volpato FCZ; Barth AL; de Tarso Roth Dalcin P; Staats CC; Vainstein MH; Kmetzsch L
    Respir Res; 2024 May; 25(1):211. PubMed ID: 38762736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Costs of outpatient parenteral antimicrobial therapy (OPAT) administered by Hospital at Home units in Spain.
    González-Ramallo VJ; Mirón-Rubio M; Mujal A; Estrada O; Forné C; Aragón B; Rivera AJ
    Int J Antimicrob Agents; 2017 Jul; 50(1):114-118. PubMed ID: 28499957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.